Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan

Ads

You May Also Like

Aptevo Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference

SEATTLE, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology ...

Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

Merger to create a late-stage, NASDAQ-listed company focused on developing novel immune therapies for ...

Apricus Biosciences Announces Pricing of $7.0 Million Public Offering

SAN DIEGO, April 21, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...